Elicio TherapeuticsELTX
那斯達克 · USD
3.05
+0.07
(+2.35%)
盤中 08/25 11:37 (UTC+8)
08/25 11:37 (UTC+8)
Elicio TherapeuticsELTX
3.05
+0.07
(+2.35%)
財務數據
損益表
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | - | - | - | - | - | - | - | - | - | - |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | - | - | - | - | - | - | - | - | - | - |
營業費用 | 10,429 | 10,602 | 8,842 | 8,045 | 10,091 | - | - | - | - | - |
研發費用 | 6,811 | 6,757 | 5,080 | 5,039 | 7,006 | 7,778 | 10,709 | 7,208 | 8,180 | 7,559 |
推銷及管理費用 | 3,618 | 3,845 | 3,762 | 3,006 | 3,085 | 2,958 | 2,767 | 3,137 | 2,744 | 2,682 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -10,429 | -10,602 | -8,842 | -8,045 | -10,091 | -10,736 | -13,476 | -10,345 | -10,924 | -10,241 |
其他收入及費用 | 2,622 | -814 | 1,461 | -1,612 | -276 | -297 | -294 | -8,357 | 3,744 | -1,550 |
利息費用 | 410 | 407 | 337 | 426 | 194 | 176 | 234 | 136 | 49 | 36 |
稅前純益 | -8,217 | -11,823 | -7,718 | -10,083 | -10,561 | -11,209 | -14,004 | -18,838 | -7,229 | -11,827 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | -8,217 | -11,823 | -7,718 | -10,083 | -10,561 | -11,209 | -14,004 | -18,838 | -7,229 | -11,827 |
基本每股稅後盈餘(元) | -0.43 | -0.65 | -0.45 | -0.60 | -0.66 | -0.87 | -1.07 | -1.39 | -0.64 | -1.15 |
稀釋每股稅後盈餘(元) | -0.42 | -0.65 | -0.49 | -0.59 | -0.63 | -0.87 | -1.02 | -1.46 | -0.62 | -1.15 |
基本平均股數(千股) | 19244.00 | 18211.00 | 15550.00 | 16692.00 | 16059.00 | 12950.00 | 13672.00 | 13582.00 | 11284.00 | 10273.00 |
稀釋平均股數(千股) | 19244.00 | 18211.00 | 15550.00 | 16692.00 | 16059.00 | 12950.00 | 13672.00 | 13582.00 | 11284.00 | 10273.00 |
還原基本每股稅後盈餘(元) | -0.43 | -0.65 | -0.45 | -0.60 | -0.66 | -0.87 | -1.07 | -1.39 | -0.64 | -1.15 |
還原稀釋每股稅後盈餘(元) | -0.42 | -0.65 | -0.49 | -0.59 | -0.63 | -0.87 | -1.02 | -1.46 | -0.62 | -1.15 |
還原基本平均股數(千股) | 19,244 | 18,211 | 15,550 | 16,692 | 16,059 | 12,950 | 13,672 | 13,582 | 11,284 | 10,273 |
還原稀釋平均股數(千股) | 19,244 | 18,211 | 15,550 | 16,692 | 16,059 | 12,950 | 13,672 | 13,582 | 11,284 | 10,273 |
EBITDA(千元) | -7,464 | -11,059 | -6,913 | -9,374 | -10,086 | -10,720 | -13,416 | -18,386 | -6,887 | -11,501 |